Here are four things to know:
1. The company expects to generate 5.5 percent to 6 percent of sales on operation basis in the third quarter of 2017.
2. Johnson & Johnson’s recent expandable cage launch is expected to add the company’s sales in the third quarter.
3. During the second quarter of 2017, Johnson & Johnson acquired Abbott Medical Optics for $4.3 billion, helping to drive sales growth. The company reported around $25 million in sales through acquired business lines for the second quarter.
4. Johnson & Johnson registered $18.8 billion in revenues in the second quarter of 2017, up around 1.6 percent year-over-year.
More articles on devices and implants:
How NICO’s BrainPath Approach & technology is ‘revolutionizing’ neurosurgery
NuVasive, Alphatec, Medtronic & more: 17 device company notes
Stryker receives $3.4M tax rebate to expand in Utah: 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
